Of course they are. Why do you think this has taken so long? The medical community is the most self-serving, conservative profession in the world.
There are some 1500 stem-cell RCT's going on around the world right now. Most in COVID. Two companies (CYP and OCC) have undertaken pivotal studies in Orthopedics. One in caritlage (knee OA), the other in tendons.
These procedures threaten a lot of what the orthopedic community presently offer and of course they are going to be resistant, particularly without large scale trial data. That's what these studies are about.
MSB taking a big hit today. OCC probably being off laid on margin calls therein.
Stem Cell Therapy advancements, page-258
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.010(2.60%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 39.5¢ | $3.89K | 9.849K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7694 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 21543 | 3 |
View Market Depth
| Last trade - 10.31am 01/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |